AT4 receptor

1.	Bureau, Annabelle: 1 article (10/2008)
2.	Achard, Jean-Michel: 1 article (10/2008)
3.	Faure, Sebastien: 1 article (10/2008)
4.	Oudart, Nicole: 1 article (10/2008)
5.	Javellaud, James: 1 article (10/2008)
6.	Fournier, Albert: 1 article (10/2008)
7.	Krishnan, R: 1 article (12/2001)
8.	Wright, J W: 1 article (12/2001)
9.	Harding, J W: 1 article (12/2001)
10.	Pederson, E S: 1 article (12/2001)

Related Diseases

1.	Thrombosis (Thrombus) 01/01/2007 - "The RAS is now recognized to be linked to induction of plasminogen activator-inhibitor-1 (PAI-1), possibly via the AT4 receptor, thus promoting both thrombosis and fibrosis" 11/01/2001 - "The RAS is now recognized to be linked to induction of plasminogen activator inhibitor-1 (PAI-1) likely via both the type 1 (AT1) and type 4 (AT4) receptors, thus, promoting both thrombosis and fibrosis" Get all the results and reference details, order at left...
2.	Memory Disorders (Memory Loss) 05/15/1999 - "Further, application of an AT4 receptor agonist compensated for spatial memory deficits in performance accompanying perforant path knife cuts" 12/15/2001 - "A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits." Get all the results and reference details, order at left...
3.	Fibrosis (Cirrhosis) 01/01/2007 - "The RAS is now recognized to be linked to induction of plasminogen activator-inhibitor-1 (PAI-1), possibly via the AT4 receptor, thus promoting both thrombosis and fibrosis" 11/01/2001 - "The RAS is now recognized to be linked to induction of plasminogen activator inhibitor-1 (PAI-1) likely via both the type 1 (AT1) and type 4 (AT4) receptors, thus, promoting both thrombosis and fibrosis" Get all the results and reference details, order at left...
4.	Stroke (Strokes) 10/01/2008 - "Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors." Get all the results and reference details, order at left...
5.	Tetanus 04/06/2001 - "Activation of AT4 receptors by Nle1-AngIV enhanced synaptic transmission during low-frequency test pulses (0.1 Hz), and increased the level of tetanus-induced LTP by 63% over that measured under control conditions" Get all the results and reference details, order at left...
5 Diseases and 6 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Scopolamine (Hyoscine)
2.	Plasminogen Activators (Plasminogen Activator)
3.	Plasminogen
4.	Angiotensins
5.	candesartan
5 Drugs and Important Bio-Agents and 4 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>